(Q40619439)

22 September 2017

Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation (English)

1 reference

22 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

29 March 2024

author name string

Martine Caron

1

1 reference

22 September 2017

Martine Auclair

2

1 reference

22 September 2017

Hélène Sterlingot

3

1 reference

22 September 2017

Michel Kornprobst

4

1 reference

22 September 2017

Jacqueline Capeau

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

22 September 2017

21 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14600514

29 March 2024

1 reference

22 September 2017

17

1 reference

22 September 2017

2437-2444

1 reference

22 September 2017

17

1 reference

Adverse effects of antiretroviral therapy

22 September 2017

1

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Insulin resistance in the HIV-lipodystrophy syndrome

29 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Antiretroviral therapy-associated hyperlipidaemia in HIV disease

29 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients

29 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

HIV protease inhibitors block adipogenesis and increase lipolysis in vitro

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes

29 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/RXR heterodimer

29 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance

29 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Effects of antiretroviral drug combinations on the differentiation of adipocytes

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

29 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy

29 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Nuclear lamins: building blocks of nuclear architecture

29 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

The inner nuclear membrane

29 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies

29 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Lessons from lipodystrophy:LMNA, encoding lamin A/C, in HIV therapy-associated lipodystrophy

29 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Nelfinavir: an update on its use in HIV infection

29 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Amprenavir: a review of its clinical potential in patients with HIV infection

29 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

29 March 2024

HIV-protease inhibitors

28

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor

29 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Indinavir plasma protein binding in HIV-1-infected adults

29 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Pharmacokinetic enhancement of protease inhibitors.

29 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice.

29 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: three-dimensional organization and protein composition

29 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

29 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

29 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00005

29 March 2024

Identifiers

1 reference

22 September 2017

1 reference